189 related articles for article (PubMed ID: 10582823)
1. Subcutaneous phytonadione for reversal of warfarin-induced elevation of the International Normalized Ratio.
Byrd DC; Stephens MA; Hamann GL; Dorko C
Am J Health Syst Pharm; 1999 Nov; 56(22):2312-5. PubMed ID: 10582823
[TBL] [Abstract][Full Text] [Related]
2. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D
Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783
[TBL] [Abstract][Full Text] [Related]
3. Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.
Patel RJ; Witt DM; Saseen JJ; Tillman DJ; Wilkinson DS
Pharmacotherapy; 2000 Oct; 20(10):1159-66. PubMed ID: 11034038
[TBL] [Abstract][Full Text] [Related]
4. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione.
Raj G; Kumar R; McKinney WP
Arch Intern Med; 1999 Dec 13-27; 159(22):2721-4. PubMed ID: 10597763
[TBL] [Abstract][Full Text] [Related]
5. Effect of Intravenous Versus Subcutaneous Phytonadione on Length of Stay for Patients in Need of Urgent Warfarin Reversal.
Mottice BL; Soric MM; Legros E
Am J Ther; 2016; 23(2):e345-9. PubMed ID: 25461960
[TBL] [Abstract][Full Text] [Related]
6. Time to Peak International Normalized Ratio Rise in Acute and Acute-on-Chronic Warfarin Overdoses.
Minhaj FS; Leonard JB; Seung H; Klein-Schwartz W
J Cardiovasc Pharmacol; 2021 Sep; 78(3):474-479. PubMed ID: 34516454
[TBL] [Abstract][Full Text] [Related]
7. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.
Dezee KJ; Shimeall WT; Douglas KM; Shumway NM; O'malley PG
Arch Intern Med; 2006 Feb; 166(4):391-7. PubMed ID: 16505257
[TBL] [Abstract][Full Text] [Related]
8. Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation.
Pengo V; Banzato A; Garelli E; Zasso A; Biasiolo A
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):739-41. PubMed ID: 8292723
[TBL] [Abstract][Full Text] [Related]
9. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
Gunther KE; Conway G; Leibach L; Crowther MA
Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy.
Shields RC; McBane RD; Kuiper JD; Li H; Heit JA
Mayo Clin Proc; 2001 Mar; 76(3):260-6. PubMed ID: 11243272
[TBL] [Abstract][Full Text] [Related]
11. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
Tsu LV; Dienes JE; Dager WE
Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
[TBL] [Abstract][Full Text] [Related]
12. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
Hanslik T; Prinseau J
Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
[TBL] [Abstract][Full Text] [Related]
13. A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin.
Fan J; Armitstead JA; Adams AG; Davis GA
Pharmacotherapy; 2003 Oct; 23(10):1245-50. PubMed ID: 14594342
[TBL] [Abstract][Full Text] [Related]
14. Phytonadione therapy in a multiple-drug overdose involving warfarin.
Bates D; Mintz M
Pharmacotherapy; 2000 Oct; 20(10):1208-15. PubMed ID: 11034045
[TBL] [Abstract][Full Text] [Related]
15. Comparing different routes and doses of phytonadione for reversing excessive anticoagulation.
Whitling AM; Bussey HI; Lyons RM
Arch Intern Med; 1998 Oct; 158(19):2136-40. PubMed ID: 9801181
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.
Kampouraki E; Avery PJ; Wynne H; Biss T; Hanley J; Talks K; Kamali F
Br J Haematol; 2017 Sep; 178(5):800-809. PubMed ID: 28771671
[TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.
Lee R; Wen A; Berube C
Am J Health Syst Pharm; 2011 May; 68(9):814-7. PubMed ID: 21515865
[TBL] [Abstract][Full Text] [Related]
18. Elevated international normalized ratio values associated with concomitant use of warfarin and ceftriaxone.
Clark TR; Burns S
Am J Health Syst Pharm; 2011 Sep; 68(17):1603-5. PubMed ID: 21856805
[TBL] [Abstract][Full Text] [Related]
19. Intravenous phytonadione administered orally in reducing warfarin-related coagulopathy.
Rice JH; Akpunonu P; Davis GA; Dugan A; Litteral J; Webb AN; Wiegand A; Bailey A; Baum RA
Clin Toxicol (Phila); 2022 Apr; 60(4):530-532. PubMed ID: 34751053
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.
Denas G; Marzot F; Offelli P; Stendardo A; Cucchini U; Russo R; Nante G; Iliceto S; Pengo V
J Thromb Thrombolysis; 2009 Apr; 27(3):340-7. PubMed ID: 18338109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
